Viatris, Ocuphire Pharma get USFDA nod for Ryzumvi for treatment of Pharmacologically-Induced Mydriasis Ruchika Sharma2 Oct 2023 11:30 AM ISTPittsburgh: Viatris Inc., a global healthcare company, and Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on...
FDA approves phentolamine ophthalmic for reversing pharmacologically-induced mydriasis Dr. Kamal Kant Kohli29 Sept 2023 11:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved RYZUMVI (phentolamine ophthalmic solution) 0.75% for reversing pharmacologically-induced...
Biocon Biologics completes integration of acquired biosimilars business from Viatris in North America Ruchika Sharma7 Sept 2023 12:16 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the Company has completed the integration of the acquired ...
Viatris gets USFDA tentative nod for paediatric formulation of Abacavir, Dolutegravir, Lamivudine for children with HIV Ruchika Sharma5 Sept 2023 3:54 PM ISTBangalore: Viatris Inc., a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug...
CCI clears Kotak Special Situations Fund investment in Biocon Biologics Ruchika Sharma14 Aug 2023 12:30 PM ISTThe combination relates to the acquirer (Kotak Special Situations Fund) proposing to purchase certain equity shares in the target (Biocon Biologics).
Biocon Biologics takes over biosimilars business from Viatris in over 70 countries Ruchika Sharma6 July 2023 11:36 AM ISTAll the biosimilar products commercialized by Viatris in various markets such as bGlargine (Semglee), bPegfilgrastim (Fulphila), bTrastuzumab...
Biocon Biologics's Hulio biosimilar to Humira, now available in US Ruchika Sharma4 July 2023 2:38 PM ISTHULIO is available at a list price (Wholesale Acquisition Cost) of 5% below the current Humira list price.
US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris Ruchika Sharma18 April 2023 11:33 AM ISTSanofi said in the lawsuit that it lost hundreds of millions of dollars in sales in the USD 1 billion-plus U.S. epinephrine auto-injector market due...
Teva, Viatris win US appeal in patent fight over Parkinson's drug Ruchika Sharma14 April 2023 4:00 PM ISTNew Delhi: Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson's disease...
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
Biocon raises Rs 1067 crore from Kotak to fund biosimilars deal Ruchika Sharma23 Feb 2023 1:00 PM IST"This investment in Biocon comes at a pivotal point when Biocon is forward integrating its biosimilars business," Srini Sriniwasan, managing director...
Biocon Q3FY23 revenue at Rs 3,020 crore, up 36 percent MD Bureau15 Feb 2023 11:15 AM IST"We reported a strong EBITDA growth of 35 percent to Rs 723 crore, representing a healthy EBITDA margin of 24 percent. Core EBITDA grew 49 percent to...
